Discovery US 2023 in Boston, November 1-2

Discovery US 2023

Join us at Discovery US and network with us and over 250 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimisation.

The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling

Click here for more information about the conference. 

Dr. Saman Honarnejad, Chief Scientific Officer at Pivot Park Screening CentreOur CSO, Saman Honarnejad, PhD, will be one of the speakers during this in-person event and will share with you his experience in the field of early drug discovery.
Be sure to join his session about Hit Profiler – An in-silico database & text mining tool for qualitative pharmacogenomic profiling of hit series & their corresponding chemical space on Wednesday November 1, 11:20 to 11:50 AM.


Want to meet our experts in person? Schedule your appointment with our experts here directly!